The hindrances to perform the COVID-19 vaccination in Brazil

Matheus Negri Boschiero1,2, Camila Vantini Capasso Palamim1,2, Fernando Augusto Lima Marson1,2

  • 1Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, São Francisco University, Bragança Paulista, SP, Brazil.

Insights

Brazil

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Brazil, a COVID-19 epicenter, faces significant challenges in its vaccination program.
  • Inefficiencies in vaccine distribution and uptake hinder effective pandemic control.

Purpose of the Study:

  • To evaluate the Brazilian COVID-19 vaccination plan.
  • To identify and discuss hindrances impacting vaccination plan efficiency.

Main Methods:

  • Analysis of vaccine distribution data.
  • Correlation analysis between vaccine allocation and demographic/epidemiological factors.
  • Review of logistical and socio-political challenges.

Main Results:

  • Geographical challenges and storage requirements impact vaccine delivery.
  • Prioritization of indigenous populations and healthcare workers influenced distribution.
  • Antivaccine movements and politicization pose significant barriers.
  • Vaccine distribution correlated strongly with COVID-19 cases, deaths, GDP, and population density, not ICU distribution or incidence/mortality rates.
  • Over 83 million vaccine doses distributed, with Coronavac, AstraZeneca, and Pfizer being primary vaccines.

Conclusions:

  • The Federal Government must address identified hindrances.
  • Implementing targeted solutions is crucial to optimize COVID-19 immunization in Brazil.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
47.3K
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
4.2K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
443
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
37